Logo image of PMO

PUTNAM MUNICIPAL OPPOR (PMO) Stock Overview

USA - NYSE:PMO - US7469221037

10.39 USD
-0.01 (-0.1%)
Last: 10/16/2025, 2:27:30 PM
Fundamental Rating

2

Taking everything into account, PMO scores 2 out of 10 in our fundamental rating. PMO was compared to 0 industry peers in the Unkown industry. While PMO seems to be doing ok healthwise, there are quite some concerns on its profitability. PMO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

PMO had positive earnings in the past year.
PMO had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: PMO reported negative operating cash flow in multiple years.
PMO Yearly Net Income VS EBIT VS OCF VS FCFPMO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M

1.2 Ratios

Industry RankSector Rank
ROA 0.66%
ROE 0.68%
ROIC 3.19%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PMO Yearly ROA, ROE, ROICPMO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

In the last couple of years the Operating Margin of PMO has remained more or less at the same level.
PMO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 83.68%
PM (TTM) 13.73%
GM 83.59%
OM growth 3Y2.15%
OM growth 5Y0.48%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.11%
GM growth 5Y0.9%
PMO Yearly Profit, Operating, Gross MarginsPMO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200

More info and screens

4

2. Health

2.1 Basic Checks

Compared to 5 years ago, PMO has less shares outstanding
PMO Yearly Shares OutstandingPMO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 10M 20M 30M
PMO Yearly Total Debt VS Total AssetsPMO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 200M 400M 600M

2.2 Solvency

An Altman-Z score of 14.67 indicates that PMO is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.02 indicates that PMO is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 14.67
ROIC/WACCN/A
WACCN/A
PMO Yearly LT Debt VS Equity VS FCFPMO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 200M 400M 600M

2.3 Liquidity

A Current Ratio of 3.06 indicates that PMO has no problem at all paying its short term obligations.
PMO has a Quick Ratio of 3.06. This indicates that PMO is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 3.06
Quick Ratio 3.06
PMO Yearly Current Assets VS Current LiabilitesPMO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

PMO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -76.92%.
Looking at the last year, PMO shows a small growth in Revenue. The Revenue has grown by 1.27% in the last year.
Measured over the past years, PMO shows a decrease in Revenue. The Revenue has been decreasing by -1.04% on average per year.
EPS 1Y (TTM)-76.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-127.54%
Revenue 1Y (TTM)1.27%
Revenue growth 3Y3.54%
Revenue growth 5Y-1.04%
Sales Q2Q%0%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PMO Yearly Revenue VS EstimatesPMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 173.17, the valuation of PMO can be described as expensive.
Compared to an average S&P500 Price/Earnings ratio of 27.53, PMO is valued quite expensively.
Industry RankSector Rank
PE 173.17
Fwd PE N/A
PMO Price Earnings VS Forward Price EarningsPMO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PMO Per share dataPMO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

PMO has a Yearly Dividend Yield of 4.35%, which is a nice return.
PMO's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 4.35%

5.2 History

PMO has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
PMO Yearly Dividends per sharePMO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
PMO Yearly Income VS Free CF VS DividendPMO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M

More info and screens

PUTNAM MUNICIPAL OPPOR

NYSE:PMO (10/16/2025, 2:27:30 PM)

10.39

-0.01 (-0.1%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)12-26 2025-12-26
Inst Owners25.83%
Inst Owner Change-0.02%
Ins Owners0.02%
Ins Owner Change0%
Market Cap291.54M
Analysts0
Price TargetN/A
Short Float %0.13%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield 4.35%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-Date11-17 2025-11-17 (0.0393)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 173.17
Fwd PE N/A
P/S 13.25
P/FCF N/A
P/OCF N/A
P/B 0.65
P/tB 0.65
EV/EBITDA N/A
EPS(TTM)0.06
EY0.58%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.78
BVpS15.89
TBVpS15.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.66%
ROE 0.68%
ROCE 4.04%
ROIC 3.19%
ROICexc 3.19%
ROICexgc 3.19%
OM 83.68%
PM (TTM) 13.73%
GM 83.59%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y15.24%
ROICexcg growth 5Y5.37%
ROICexc growth 3Y15.32%
ROICexc growth 5Y5.42%
OM growth 3Y2.15%
OM growth 5Y0.48%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.11%
GM growth 5Y0.9%
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.06
Quick Ratio 3.06
Altman-Z 14.67
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-127.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.27%
Revenue growth 3Y3.54%
Revenue growth 5Y-1.04%
Sales Q2Q%0%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.82%
EBIT growth 3Y5.76%
EBIT growth 5Y-0.57%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A